Form 4: HCA Healthcare Director Michelson Reports Acquisition and Disposal of Common Stock

Sentiment:

SEC Form 4 Filing


Director Michael Michelson reports acquiring and disposing of HCA Healthcare common stock related to restricted share units.

Summary

  • Michael Michelson, a director at HCA Healthcare, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On April 29, 2024, Michelson acquired 1,091 shares of common stock at $0.00, representing restricted share units.
  • These units are attributable to an annual director equity award (610 units) and shares received in lieu of annual cash retainers (481 units).
  • Michelson also disposed of 10,478 shares.
  • The restricted share units will vest on the earlier of the 2025 annual shareholders' meeting or the first anniversary of the grant date.
  • Vested shares will be delivered upon Michelson ceasing to be a member of the Board of Directors.
  • Michelson has granted power of attorney to John M. Franck II, Natalie Harrison Cline, and Kevin A. Ball to handle SEC filings related to HCA Healthcare securities.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, so the sentiment is neutral. It reflects standard compensation practices and insider transactions.

Positives

  • The acquisition of restricted share units aligns the director's interests with those of the shareholders.
  • The use of equity in lieu of cash retainers can conserve company cash.

Future Outlook

The restricted share units will vest on the earlier of the 2025 annual shareholders' meeting or the first anniversary of the grant date, aligning the director's compensation with the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices for board members.

Comparison to Industry Standards

  • Director compensation packages often include a mix of cash and equity.
  • Restricted share units are a common tool to align director interests with shareholder value, similar to practices at companies like Tenet Healthcare and Universal Health Services.
  • The vesting schedule is typical, often tied to continued service on the board.

Stakeholder Impact

  • Shareholders are informed about director compensation and alignment of interests.
  • The filing provides transparency into insider transactions.

Key Dates

DateDescription
2017-11-07Date of Power of Attorney execution.
2024-04-29Date of transaction (acquisition and disposal of shares).
2024-05-01Date of signature for the Form 4 filing.
2025Restricted share units vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.